Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults

Conditions

• Tuberculosis

Interventions

• BIOLOGICAL: GSK's candidate Mycobacterium tuberculosis vaccine 692342
• BIOLOGICAL: Comparator vaccine with recombinant Mycobacterium tuberculosis antigen and adjuvant system
• BIOLOGICAL: Comparator vaccine with recombinant Mycobacterium tuberculosis antigen and physiological saline
• BIOLOGICAL: Control vaccine with the adjuvant system.

Sponsor

GlaxoSmithKline